Foreign-Trade Zone 7 - - Mayaguez, Puerto Rico, Application for Temporary/Interim Manufacturing Authority, Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., (Pharmaceutical Products), Caguas, Puerto Rico, 27801 [E7-9539]

Download as PDF Federal Register / Vol. 72, No. 95 / Thursday, May 17, 2007 / Notices pwalker on PROD1PC71 with NOTICES Comment Requested This notice of intent initiates the scoping process which guides the development of the environmental impact statement. The Nez Perce National Forest is seeing comments and issues you may have regarding this project. Comments are most useful if they are specific. Early Notice of Importance of Public Participation in Subsequent Environmental Review: A draft environmental impact statement will be prepared for comment. The comment period on the draft environmental impact statement will be 45 days from the date the Environmental Protection Agency publishes the notice of availability in the Federal Register. The Forest Service believes, at this early stage, it is important to give reviewers notice of several court rulings related to public participation in the environmental review process. First, reviewers of draft environmental impact statements must structure their participation in the environmental review of the proposal so that it is meaningful and alerts an agency to the reviewer’s position and contentions. Vermont Yankee Nuclear Power Corp. v. NRDC, 435 U.S. 519,553 (1978). Also, environmental objections that could be raised at the draft environmental impact statement stage but that are not raised until after completion of the final environmental impact statement may be waived or dismissed by the courts. City of Angoon v. Hodel, 803 F.2d 1016, 1022 (9th Cir. 1986) and Wisconsin Heritages, Inc. v. Harris, 490 F. Supp. 1334, 1338 (E.D. Wis. 1980). Because of these court rulings, it is very important that those interested in this proposed action participate by the close of the 45 day comment period so that comments and objections are made available to the Forest Service at a time when it can meaningfully consider them and respond to them in the final environmental impact statement. To assist the Forest Service in identifying and considering issues nd concerns on the proposed action, comments on the draft environmental impact statement should be as specific as possible. It is also helpful if comments refer to specific pages or chapters of the draft statement. Comments may also address the adequacy of the draft environmental impact statement or the merits of the alternatives formulated and discussed in the statement. Reviewers may wish to refer to the Council on Environmental Quality Regulations for implementing the procedural provisions of the VerDate Aug<31>2005 17:15 May 16, 2007 Jkt 211001 National Environmental Policy Act at 40 CFR 1503.3 in addressing these points. Comments received, including the names and addresses of those who comment, will be considered part of the public record on this proposal and will be available for public inspection. (Authority: 40 CFR 1501.7 and 1508.22; Forest Service Handbook 1909.15, Section 21.) Dated: May 10, 2007. Jane L. Cottrell, Nez Perce National Forest Supervisor. [FR Doc. 07–2419 Filed 5–16–07; 8:45 am] BILLING CODE 3410–11–M DEPARTMENT OF COMMERCE Foreign–Trade Zones Board [Docket T–3–2007] Foreign–Trade Zone 7 - - Mayaguez, Puerto Rico, Application for Temporary/Interim Manufacturing Authority, Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., (Pharmaceutical Products), Caguas, Puerto Rico An application has been submitted to the Executive Secretary of the Foreign– Trade Zones Board (the Board) by the Puerto Rico Industrial Development Company (PRIDCO), grantee of FTZ 7, requesting temporary/interim manufacturing (T/IM) authority within FTZ 7 at the MOVA Pharmaceutical Corporation (MOVA) facility in Caguas, Puerto Rico, on behalf of Merck Sharp & Dohme Quimica De Puerto Rico, Inc. (MSDQ). The application was filed on May 10, 2007. The MOVA facility (650 employees, 250,000 sq. ft.) is located at State Road 1, Km 34.8, within the Villa Blanca Industrial Park in Caguas (Site 1, Parcel 2). T/IM procedures would be used for pharmaceutical manufacturing involving two products, MK–431A and sitagliptin (HTSUS 3004.90 and 2933.59) on behalf of MSDQ for the U.S. market and export. Foreign components that would be used in the manufacturing process (up to 25% of total content) include sitagliptin, metformin hydrochloride, enamine amide and butyl josphos (duty rates of 3.7 to 6.5%). MSDQ has also submitted a request for permanent FTZ manufacturing authority (which will be docketed with the Board separately). FTZ procedures would exempt MSDQ from Customs duty payments on foreign components used in production for export to non–NAFTA countries. For domestic and NAFTA markets, MSDQ could select the duty rate that applies to PO 00000 Frm 00002 Fmt 4703 Sfmt 4703 27801 the finished product (duty–free to 6.5%) for the components used in production when the finished products are entered for U.S. consumption from the zone. The application indicates that the company would also realize duty deferral and certain logistical/supply chain savings. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at the following address: Office of the Executive Secretary, Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., Washington, DC 20230. The closing period for receipt of comments is June 18, 2007. A copy of the application will be available for public inspection at the Office of the Foreign–Trade Zones Board’s Executive Secretary at the address listed above. For further information, contact Christopher Kemp at: christopherlkemp@ita.doc.gov, or (202) 482–0862. Dated: May 10, 2007. Andrew McGilvray, Executive Secretary. [FR Doc. E7–9539 Filed 5–16–07; 8:45 am] BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE International Trade Administration [A–201–830] Carbon and Certain Alloy Steel Wire Rod from Mexico: Extension of Time Limits for the Preliminary Results of Antidumping Duty Administrative Review Import Administration, International Trade Administration, Department of Commerce. FOR FURTHER INFORMATION CONTACT: Jolanta Lawska or John Conniff, AD/ CVD Operations, Office 3, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Ave, NW., Washington, DC 20230; telephone: (202) 482–8362 or (202) 482– 1009, respectively. SUPPLEMENTARY INFORMATION: AGENCY: Background On November 27, 2006, the Department of Commerce (‘‘Department’’) published a notice of initiation of the administrative review of the antidumping duty order on carbon and certain alloy steel wire rod from Mexico, covering the period October 1, 2005, to September 30, 2006. See Initiation of Antidumping and E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 72, Number 95 (Thursday, May 17, 2007)]
[Notices]
[Page 27801]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9539]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket T-3-2007]


Foreign-Trade Zone 7 - - Mayaguez, Puerto Rico, Application for 
Temporary/Interim Manufacturing Authority, Merck Sharpe & Dohme Quimica 
De Puerto Rico, Inc., (Pharmaceutical Products), Caguas, Puerto Rico

    An application has been submitted to the Executive Secretary of the 
Foreign-Trade Zones Board (the Board) by the Puerto Rico Industrial 
Development Company (PRIDCO), grantee of FTZ 7, requesting temporary/
interim manufacturing (T/IM) authority within FTZ 7 at the MOVA 
Pharmaceutical Corporation (MOVA) facility in Caguas, Puerto Rico, on 
behalf of Merck Sharp & Dohme Quimica De Puerto Rico, Inc. (MSDQ). The 
application was filed on May 10, 2007.
    The MOVA facility (650 employees, 250,000 sq. ft.) is located at 
State Road 1, Km 34.8, within the Villa Blanca Industrial Park in 
Caguas (Site 1, Parcel 2). T/IM procedures would be used for 
pharmaceutical manufacturing involving two products, MK-431A and 
sitagliptin (HTSUS 3004.90 and 2933.59) on behalf of MSDQ for the U.S. 
market and export. Foreign components that would be used in the 
manufacturing process (up to 25[percnt] of total content) include 
sitagliptin, metformin hydrochloride, enamine amide and butyl josphos 
(duty rates of 3.7 to 6.5[percnt]). MSDQ has also submitted a request 
for permanent FTZ manufacturing authority (which will be docketed with 
the Board separately).
    FTZ procedures would exempt MSDQ from Customs duty payments on 
foreign components used in production for export to non-NAFTA 
countries. For domestic and NAFTA markets, MSDQ could select the duty 
rate that applies to the finished product (duty-free to 6.5[percnt]) 
for the components used in production when the finished products are 
entered for U.S. consumption from the zone. The application indicates 
that the company would also realize duty deferral and certain 
logistical/supply chain savings.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the following address: Office of the Executive Secretary, 
Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., 
Washington, DC 20230. The closing period for receipt of comments is 
June 18, 2007.
    A copy of the application will be available for public inspection 
at the Office of the Foreign-Trade Zones Board's Executive Secretary at 
the address listed above. For further information, contact Christopher 
Kemp at: christopher_kemp@ita.doc.gov, or (202) 482-0862.

    Dated: May 10, 2007.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E7-9539 Filed 5-16-07; 8:45 am]
BILLING CODE 3510-DS-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.